Immix Biopharma Inc (NASDAQ: IMMX) on Tuesday, plunged -4.17% from the previous trading day, before settling in for the closing price of $5.51. Within the past 52 weeks, IMMX’s price has moved between $1.34 and $7.73.
During the last 5-year period, the sales drop of Healthcare Sector giant was -43.61%. The company achieved an average annual earnings per share of -1.40%. With a float of $33.53 million, this company’s outstanding shares have now reached $52.70 million.
Immix Biopharma Inc (IMMX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immix Biopharma Inc is 36.37%, while institutional ownership is 5.49%. The most recent insider transaction that took place on Dec 10 ’25, was worth 4,976. In this transaction CEO and Chairman of this company bought 746 shares at a rate of $6.67, taking the stock ownership to the 1,141,683 shares. Before that another transaction happened on Dec 10 ’25, when Company’s CFO bought 770 for $6.58, making the entire transaction worth $5,067. This insider now owns 291,429 shares in total.
Immix Biopharma Inc (IMMX) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.15 earnings per share (EPS) for the period topping the consensus outlook (set at -0.25) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.40% per share during the next fiscal year.
Immix Biopharma Inc (NASDAQ: IMMX) Trading Performance Indicators
Immix Biopharma Inc (IMMX) is currently performing well based on its current performance indicators. A quick ratio of 1.53 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Immix Biopharma Inc (IMMX)
Looking closely at Immix Biopharma Inc (NASDAQ: IMMX), its last 5-days average volume was 0.92 million, which is a jump from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 11.57%.
During the past 100 days, Immix Biopharma Inc’s (IMMX) raw stochastic average was set at 57.69%, which indicates a significant increase from 0.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.58 in the past 14 days, which was higher than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.53, while its 200-day Moving Average is $2.78. However, in the short run, Immix Biopharma Inc’s stock first resistance to watch stands at $5.52. Second resistance stands at $5.76. The third major resistance level sits at $5.89. If the price goes on to break the first support level at $5.15, it is likely to go to the next support level at $5.02. Should the price break the second support level, the third support level stands at $4.78.
Immix Biopharma Inc (NASDAQ: IMMX) Key Stats
Market capitalization of the company is 278.23 million based on 33,578K outstanding shares. Right now, sales total 0 K and income totals -21,610 K. The company made 0 K in profit during its latest quarter, and -7,590 K in sales during its previous quarter.
